-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Drin8zGy7Qog3GE4dPQ4spJnEJouZ1Q9ODOn8t1TdKh8vKw5nA/S4QpI5vp3xqcu y1PduNWXwZC4GmYkhevz2Q== 0001082554-03-000004.txt : 20030722 0001082554-03-000004.hdr.sgml : 20030722 20030722141317 ACCESSION NUMBER: 0001082554-03-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030718 FILED AS OF DATE: 20030722 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JEFFS ROGER CENTRAL INDEX KEY: 0001231615 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 03796190 BUSINESS ADDRESS: STREET 1: C/O UNITED THERAPEUTICS CORP STREET 2: 1110 SPRING STREET CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS CORP CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 4 1 primary_doc.xml PRIMARY DOCUMENT 4 2003-07-18 0 0001082554 UNITED THERAPEUTICS CORP UTHR 0001231615 JEFFS ROGER 1 1 0 0 President and COO Common Stock 2003-07-18 2003-07-18 4 M 0 9333 3 A 23345 D Common Stock 2003-07-18 2003-07-18 4 S 0 1333 18.4 D 22012 D Common Stock 2003-07-18 2003-07-18 4 S 0 1500 18.25 D 20512 D Common Stock 2003-07-18 2003-07-18 4 S 0 6500 18.23 D 14012 D Stock Options 3 2003-07-18 2003-07-18 4 M 0 9333 0 D 2001-09-15 2003-09-24 Common Stock 9333 432172 D The exercise of stock options that otherwise would have expired on September 24, 2003 and the corresponding sale of 9,333 shares of common stock (the "Shares") reported on this Form 4 are pursuant to the 10b5-1 Plan adopted by the Reporting Person on May 13, 2003. All proceeds from the sale of Shares after tax witholding will be applied toward the payment of principal and interest of United Therapeutics' April 2002 loan to the Reporting Person to purchase his primary residence. Paul A. Mahon under Power of Attorney 2003-07-18 -----END PRIVACY-ENHANCED MESSAGE-----